Back to Search
Start Over
The Need for Diagnosis-Related Group 471
- Source :
- JAMA. 253:684
- Publication Year :
- 1985
- Publisher :
- American Medical Association (AMA), 1985.
-
Abstract
- TODAY we face a crisis in clinical research that demands that attention be directed to a problem that physicians have not had to worry about in the past: the impact of reimbursement for patient care on the progress of medical science. Until this year, the costs for patients involved in clinical trials were paid in two ways: the research costs of data collection and analysis, experimental drugs, and such were paid by research grants; the patient-care costs were paid by the patient or the insurance carrier. The advent of the prospective payment system and diagnosis-related group (DRG) reimbursement dramatically alters this system and changes the incentives. Under the DRG system, the hospital receives a fee fixed by diagnosis, and administrators are likely to show little enthusiasm for anything that increases the cost of care. Extra laboratory tests or x-ray films beyond a bare minimum will not be encouraged. The pattern
- Subjects :
- medicine.medical_specialty
business.industry
media_common.quotation_subject
Alternative medicine
Diagnosis-related group
General Medicine
medicine.disease
Clinical trial
Clinical research
Incentive
medicine
Medical emergency
Prospective payment system
Worry
business
health care economics and organizations
Reimbursement
media_common
Subjects
Details
- ISSN :
- 00987484
- Volume :
- 253
- Database :
- OpenAIRE
- Journal :
- JAMA
- Accession number :
- edsair.doi...........c83b7cd03410dbffe016f80f648006c7